Everolimus- and Temsirolimus-Associated Enteritis: Report of Three Cases

Updates of mTOR Inhibitors

(2012) Hongyu Zhou et al.   Anti-Cancer Agents in Medicinal Chemistry

Emergent toxicities associated with the use of mTOR inhibitors in patients with advanced renal carcinoma

(2010) Jesus Rodriguez-Pascual et al.   ANTI-CANCER DRUGS

Rituximab

(2010) Gillian M. Keating   DRUGS

Phase II Trial of Bevacizumab and Everolimus in Patients With Advanced Renal Cell Carcinoma

(2010) John D. Hainsworth et al.   JOURNAL OF CLINICAL ONCOLOGY

Severe Ulcerative Colitis After Rituximab Therapy

(2010) D. S. Ardelean et al.   PEDIATRICS

Clinical Outcome in Metastatic Renal Cell Carcinoma Patients After Failure of Initial Vascular Endothelial Growth Factor-Targeted Therapy

(2010) Michael M. Vickers et al.   UROLOGY

Targeting the PI3K/Akt/mTOR pathway: Effective combinations and clinical considerations

(2008) J LOPICCOLO et al.   DRUG RESISTANCE UPDATES

Temsirolimus in Renal Cell Carcinoma

(2008) T. Otto et al.   TRANSPLANTATION PROCEEDINGS